Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Lilly weekly diabetes drug succeeds vs market leader Victoza -study
Yahoo/Reuters
Tuesday, February 25, 2014 - 8:15am
tags:
Eli Lilly, diabetes, Victoza, Novo Nordisk, dulaglutide
InterMune Hits Home Run With Pivotal Lung Drug Study Results
TheStreet.com
Tuesday, February 25, 2014 - 8:14am
tags:
InterMune, pirfenidone, IPF, idiopathic pulmonary fibrosis
Verastem acquires the license to VS-4718 originally held by Poniard
Yahoo/Fly on the Wall
Tuesday, February 25, 2014 - 7:38am
tags:
Verastem, VS-4718, Poniard, stem cells
Ranbaxy halts drug ingredient shipments from two plants as scrutiny mounts
Yahoo/Reuters
Tuesday, February 25, 2014 - 7:29am
tags:
India, Ranbaxy, drug manufacturing
Public Citizen says FDA should add heart warning to popular testosterone drugs for men
Yahoo/AP
Tuesday, February 25, 2014 - 7:27am
tags:
FDA, testosterone, Public Citizen, Androgel, Androderm, Fortesta, Axiron, Watson Pharmaceuticals, AbbVie, Eli Lilly, Endo Health Solutions
Pharmaceutical Strength Expected To Continue With Questcor Tuesday
Seeking Alpha
Tuesday, February 25, 2014 - 7:25am
tags:
earnings, Questcor
3 Things to Watch at Gilead
Motley Fool
Tuesday, February 25, 2014 - 7:24am
tags:
Gilead Sciences, Sovaldi, HIV, hepatitis C
Can Horizon Pharma (HZNP) Run Higher on Strong Earnings Estimate Revisions?
Yahoo/Zacks.com
Tuesday, February 25, 2014 - 7:23am
tags:
Horizon Pharma, earnings
5 Pharmas Spending the Most to Develop Drugs: Merck, AstraZeneca, Roche, Bristol, and Lilly
Motley Fool
Tuesday, February 25, 2014 - 7:22am
tags:
Merck, AstraZeneca, Roche, Bristol-Myers Squibb, Eli Lilly, R&D, drug development
VIVUS' Q4 Loss Shrinks 70% as Licensing Revenue Soars
Motley Fool
Monday, February 24, 2014 - 5:39pm
tags:
Vivus, earnings
Cheaper Obesity Drugs Available (for Half of Some Americans)
Daily Finance
Monday, February 24, 2014 - 5:25pm
tags:
obesity, Arena Pharmaceuticals, Eisai, Vivus, Orexigen, Belviq, Qsymia, Contrave
FDA Denies 3 Petitions Seeking NCE Exclusivity for Combo Drugs, But Proposes to Reinterpret the Law for New NDAs
FDA Law Blog
Monday, February 24, 2014 - 5:18pm
tags:
FDA, exclusivity
Syneron names new CEO, beats The Street and buys New Star Lasers
Mass Device
Monday, February 24, 2014 - 5:15pm
tags:
Syneron, earnings, M&A, New Star Lasers, devices
With Teva's Symbicort copy nearing EU launch, AstraZeneca preps for battle
Fierce Pharma
Monday, February 24, 2014 - 5:11pm
tags:
Symbicort, generics, Europe, AstraZeneca, Teva Pharmaceuticals
Will the generics M&A surge put Teva on the takeover table?
Fierce Pharma
Monday, February 24, 2014 - 5:08pm
tags:
generics, M&A, Teva Pharmaceuticals
Biotech: Too Big for Its Britches?
Barron's
Monday, February 24, 2014 - 5:05pm
tags:
biotech, Celgene, Gilead Sciences, Biogen Idec, Amgen, Regeneron
Here's Why You Should Look Beyond NICE's Pushback on Tecfidera
Motley Fool
Monday, February 24, 2014 - 5:01pm
tags:
Tecfidera, NICE, MS, multiple sclerosis, Biogen Idec
Jazz Pharma To Guide 2014 With New Drugs On Board
Investors.com
Monday, February 24, 2014 - 4:59pm
tags:
Jazz Pharmaceuticals, ADX-N05, earnings
Isis Pharma Soars on Positive Data
Yahoo/Zacks.com
Monday, February 24, 2014 - 4:50pm
tags:
Isis Pharmaceuticals, ISIS-SMNRx, spinal muscular atrophy
Celsion Announces FDA Clearance of the OPTIMA Study - A Pivotal Phase III Trial of ThermoDox in Primary Liver Cancer
Yahoo
Monday, February 24, 2014 - 11:16am
tags:
FDA, Celsion, liver cancer, ThermoDox

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.